Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome observed in high-risk neuroblastoma
Disease recurrence is frequent in high-risk neuroblastoma (NBL) patients even after multimodality aggressive treatment [a combination of chemotherapy, surgical resection, local radiation therapy, autologous stem cell transplantation (ASCT) and cis-retinoic acid (CRA)]. Recent clinical studies have e...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2012-05-01
|
| Serier: | Frontiers in Pharmacology |
| Fag: | |
| Online adgang: | http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00091/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
